Biosense Webster enrolls first patient in US IDE study of Qdot Micro RF ablation catheter

03:55 EST 5 Feb 2019 | Compelo Medical Devices

As part of the US investigational device exemption (IDE) study, Biosense Webster has treated the first AF patient with the Qdot Micro ablation catheter at NYU Langone Health’s

The post Biosense Webster enrolls first patient in US IDE study of Qdot Micro RF ablation catheter appeared first on Compelo Medical Devices.

More From BioPortfolio on "Biosense Webster enrolls first patient in US IDE study of Qdot Micro RF ablation catheter"